Friday, September 11, 2015

While We Await Word. . . Some Rainy Friday Miscellany

The electronic files contain nothing new on the finasteride MDL hearing of yesterday in Brooklyn yet.

So -- while we wait -- I'll update an earlier item on an Avelox® series of claims, that have been designated as an MDL, in the District of Minnesota.

You will likely well-recall that Merck's counsel found himself in some hot water, in the Northern District of Illinois, over a perceived failure to comply with the "plain English" notice pleading requirements, under the federal civ pro rules. That case, called Hobbs v. Merck, et al., has been transferred into the MDL in Minnesota -- so we will follow it there. This new coordinated proceeding (established in mid-August) will be known as MDL 2642, and is assigned to the Chief Judge:

. . . .TRANSFER ORDER from the Judicial Panel on Multidistrict Litigation pursuant to 28 U.S.C. § 1407 that the actions listed on Schedule A and pending outside the District of Minnesota are transferred to the District of Minnesota, creating MDL 2642. MDL 2642 assigned to Chief Judge John R. Tunheim. . . .

Now you know. And so we await word on what transpired yesterday in Brooklyn, on the other -- Propecia® MDL. Onward, with a goofy big grin!

No comments: